References
- On SC, Zeichner J. Isotretinoin updates. Dermatol Ther 2013;26:377–389
- Rigopoulos D, Larios G, Katsambas AD. The role of isotretinoin in acne therapy: why not as first-line therapy? Facts and controversies. Clin Dermatol 2010;28:24–30
- Layton A. The use of isotretinoin in acne. Dermatoendocrinology 2009;1:162–169
- Orfanos CE, Zouboulis CC, Almond-Roesler B, Geilen CC. Current use and future potential role of retinoids in dermatology. Drugs 1997;53:358–388
- Brelsford M, Beute TC. Preventing and managing the side effects of isotretinoin. Semin Cutan Med Surg 2008;27:197–206
- Brito Mde F, Sant'Anna IP, Galindo JC, et al. Evaluation of clinical adverse effects and laboratory alteration in patients with acne vulgaris treated with oral isotretinoin. An Bras Dermatol 2010;85:331–337
- Del Rosso JQ. Clinical relevance of skin barrier changes associated with the use of oral isotretinoin: the importance of barrier repair therapy in patient management. J Drugs Dermatol 2013;12:626–631
- Kmieć ML, Pajor A, Broniarczyk-Dyła G. Evaluation of biophysical skin parameters and assessment of hair growth inpatients with acne treated with isotretinoin. Postepy Dermatol Alergol 2013;30:343–349
- Kellock DJ, Parslew R, Mendelsohn SS, O’Mahony CP. Non-specific urethritis – possible association with isotretinoin therapy. Int J STD AIDS 1996;7:135–136
- Edwards S, Sonnex C. Urethritis associated with isotretinoin therapy. Acta Derm Venereol 1997;77:330–331